Home > Insider Trading > Filing (0001209191-21-014013)

Filing Details

Accession Number:: 0001209191-21-014013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-24 19:53:59
Reporting Period:: 2021-02-22

Accepted Time:: 2021-02-24 19:53:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1609320	Werner Kroll	9975 Summers Ridge Road San Diego CA 92121	Svp, R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-22	3,585	$21.08	21,822	No	4	M	Direct
Common Stock	Acquisiton	2021-02-22	2,303	$46.41	24,125	No	4	M	Direct
Common Stock	Acquisiton	2021-02-22	2,970	$47.85	27,095	No	4	M	Direct
Common Stock	Acquisiton	2021-02-22	3,926	$59.12	31,021	No	4	M	Direct
Common Stock	Disposition	2021-02-22	12,784	$164.11	18,237	No	4	S	Direct
Common Stock	Disposition	2021-02-23	4,662	$166.36	13,575	No	4	S	Direct
Common Stock	Disposition	2021-02-23	173	$164.59	13,402	No	4	S	Direct
Common Stock	Disposition	2021-02-24	5,283	$173.71	8,119	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options	Disposition	2021-02-22	3,585	$0.00	3,585	$21.08
Common Stock	Non-Qualified Stock Options	Disposition	2021-02-22	2,303	$0.00	2,303	$46.41
Common Stock	Non-Qualified Stock Options	Disposition	2021-02-22	2,970	$0.00	2,970	$47.85
Common Stock	Non-Qualified Stock OPtions	Disposition	2021-02-22	3,926	$0.00	3,926	$59.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2027-02-15	No	4	M	Direct
2,303		2028-01-16	No	4	M	Direct
0	2021-01-29	2028-01-29	No	4	M	Direct
3,924		2029-02-04	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $164.1079 per share, with a range of $163.043 to $166.21. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $166.3629 per share, with a range of $164.33 to $167.61. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $173.7145 per share, with a range of $172.41 to $174.90. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
7,172 shares vested on the second anniversary date of the grant date, February 15, 2019; 3,588 shares vested on the third anniversary date of the grant date, February 15, 2020; and 3,585 shares vested on the fourth anniversary date of the grant date, February 15, 2021.
4,606 shares vested on the second anniversary date of the grant date, January 16, 2020; 2,303 shares vested on the third anniversary date of the grant date, January 16, 2021; and 2,303 shares will vest on the fourth anniversary date of the grant date, January 16, 2022.
3,926 shares vested on the second anniversary date of the grant date, February 4, 2021; 1,962 shares will vest on the third anniversary date of the grant date, February 4, 2022; and 1,962 shares will vest on the fourth anniversary date of the grant date, February 4, 2023.